Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world
Abstract:EDITORIAL
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the worldOs medicamentos que modificam a história natural da esclerose múltipla devem ser disponibilizados a todos os doentes segundo normas terapêuticas adequadas às diferentes regiões do globo Maria José Sá S ince the early nineties of the XX century, multiple sclerosis (MS) moved drastically from a scarcely treated disease to a neurological chronic conditio… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.